| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Venture Capital > Gearing Up Support from A Venture Capital Company |
|
E-Folder - Gearing Up Support from A Venture Capital Company
One of the most important things in order to start a business is a plan. Why? This is because more than 85% of those According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product who invested fail with the inclination that money is all that is needed. Having a good business plan is like build ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ing a house using bricks instead of sticks. This will have the vision and objective of the company, how much is need lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ed, the sales projections and the return of investment. This will serve like a guide to be able to foresee certain here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe problems and have contingencies in place to deal with it. Of course, the entrepreneur will still have to worry abou d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro t money. But a sound business plan will surely invite a venture capitalist. This individual could either work alone ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc or is a part of a bigger organization. Maybe the person has no time to do it but sees the entrepreneur thinking in easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the same direction and will like to see how this turns out. Since most startups are risky with the possibility of fa nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ilure, this individual will also like to play an active role in the business. The venture capitalist is usually som and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ eone who is familiar with the industry that the entrepreneur wants to engage in. This means that person may know the ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ins and outs so that mistakes can be avoided and surging the business forward. Where does the person find the pers ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a on or the company? The entrepreneur can start by asking some friends or those at work should this by the step toward dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod s leaving the regular job and spending more time in this endeavor. After getting a few references, it is time to wr cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ite a letter together with the business plan to give the prospective investor what this is all about. A formal meeti tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ng will usually take place after that and if everything goes well, then the money will start pouring in. Venture ca t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel pitalist companies have helped a lot of starters in the information technology industry. The same thing can happen f ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust or the individual regardless of the field one is coming from because there are people out there who have the money a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nd are just waiting for the right opportunity. Does the individual have what it takes to come up with a business pl . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de an and then sell it to someone who has the money? That is going to be the question the entrepreneur has to ask onese elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip lf because these the venture capital company will also be reviewing other proposals with the same promise of returns tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:New Grads Don't Have to Settle for Bad Jobs!
|